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A 15-residue peptide dimer G15 derived from the cell lytic protein granulysin has been shown to exert potent activity against microbes,
including E. coli, but not against human Jurkat cells [Z. Wang, E. Choice, A. Kaspar, D. Hanson, S. Okada, S.C. Lyu, A.M. Krensky, C.
Clayberger, Bactericidal and tumoricidal activities of synthetic peptides derived from granulysin. J. Immunol. 165 (2000) 1486–1490]. We
investigated the target membrane selectivity of G15 using fluorescence, circular dichroism and 31P NMR methods. The ANS uptake assay shows
that the extent of E. coli outer membrane disruption depends on G15 concentration. 31P NMR spectra obtained from E. coli total lipid bilayers
incorporated with G15 show disruption of lipid bilayers. Fluorescence binding studies on the interaction of G15 with synthetic liposomes formed
of E. coli lipids suggest a tight binding of the peptide at the membrane interface. The peptide also binds to negatively charged POPC/POPG (3:1)
lipid vesicles but fails to insert deep into the membrane interior. These results are supported by the peptide-induced changes in the measured
isotropic chemical shift and T1 values of POPG in 3:1 POPC:POPG multilamellar vesicles while neither a non-lamellar phase nor a fragmentation
of bilayers was observed from NMR studies. The circular dichroism studies reveal that the peptide exists as a random coil in solution but folds into
a less ordered conformation upon binding to POPC/POPG (3:1) vesicles. However, G15 does not bind to lipid vesicles made of POPC/POPG/Chl
(9:1:1) mixture, mimicking tumor cell membrane. These results explain the susceptibility of E. coli and the resistance of human Jurkat cells to
G15, and may have implications in designing membrane-selective therapeutic agents.
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Granulysin, a 9-kDa bactericidal protein present in human
cytotoxic T cells, disrupts lipid membranes [1,2] and inducesAbbreviations: ANS, anilinonaphthalene-8-sulfonic acid; CD, circular
dichroism; Chl, cholesterol; HII, inverted hexagonal phase; MIC, minimum
inhibitory concentration; MAS, magic angle spinning; NMR, nuclear magnetic
resonance; POPC, 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphatidylcholine;
POPG, 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphatidylglycerol; SUVs, small
unilamellar vesicles
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doi:10.1016/j.bbamem.2006.02.014apoptosis in mammalian cells [3]. Granulysin exhibits potent
cell lytic activity against both Gram-positive and Gram-
negative bacteria, fungi, parasites and tumor cells, including
Mycobacterium tuberculosis and Mycobacterium leprae [4].
The MIC value for granulysin against E. coli is 1.25 μM [5].
The crystal structure of granulysin revealed the presence of five
helical segments held together by two disulfide linkages and
resembles other “saposin folds” such as porcine NK-lysin [6],
saposins A and C [7], the cyclic peptide bacteriocin AS-48 [8],
one domain of prophytepsin [9] and amoebapores [10]. Cys-7 in
helix 1 (residues 3–18) and Cys-70 in helix 5 (residues 66–72),
and Cys-34 in helix-2 (residues 23–36) and Cys-45 in helix-3
(residues 42–51) are linked by disulfide linkages [11]. The
helices are amphipathic and consist of 12 arginine and 3 lysins.
To determine the minimum active portion of granulysin protein
155A. Ramamoorthy et al. / Biochimica et Biophysica Acta 1758 (2006) 154–163retaining antimicrobial activity, lytic activities of several
synthetic peptide fragments derived from granulysin have
been investigated [1]. It was shown that helices 2 and 3 are
important for the cell lytic activity of granulysin as the peptide
G8 corresponding to the helix-2–loop–helix-3 region (residues
23–51) exhibit lytic activities against bacteria and human cells
[1,12]. On the other hand, peptides containing either helix 2 or
helix 3 lyse bacteria, while only peptides containing helix 3 lyse
tumor targets and the peptides corresponding to the amino or
carbonyl regions are not lytic. It was also reported that the two
positively charged arginines (Arg-38 and Arg-40) in the loop
region between helices 2 and 3 are thought to be important for
lysis of tumor cells while lysis of human cells is dependent on
the helix-3 sequence [1]. While these functional studies are
exciting, the details on the peptide–membrane interactions that
lead to the lytic activities of these peptides have not been
investigated. In this study, we investigate the nature of lipid–
peptide interactions, as the differences in the nature of
interactions may provide the basis for the development of
membrane selective antibiotics.
One of the important peptide fragments, G15, was designed
to examine the role of the arginine residues. G15 corresponding
to the residues 37–51 of granulysin was synthesized by
substituting both the arginine residues (Arg-38 and Arg-40)
with glutamine residues. The G15 peptide has been shown to
exhibit reduced lytic activity against bacteria and human Jurkat
cells [1]. As such, the G15 peptide monomer has 3 cationic
charges and shows neither antimicrobial nor antitumor
activities. However, under non-reducing conditions, the peptide
undergoes dimerization through intermolecular S–S linkage
resulting in a 30-residue G15 peptide with 6 cationic charges
(Fig. 1).
The purpose of the present study was to understand the
specific interactions of G15 with different model membranes,
which might form the basis for the cell selective interactions of
the peptide. We investigated the E. coli outer membrane
disruption induced by G15 using the ANS uptake assay. The
peptide's ability to permeabilize bacterial inner membrane was
studied using 31P and 2H NMR experiments. The intrinsic
tryptophan fluorescence was used as a probe to obtain
information on the membrane bound peptide. The binding
interactions of G15 and peptide-induced dye leakage were
investigated using liposomes formed of E. coli lipids, POPC/
POPG (3:1), and POPC/POPG/Chl (9:1:1) lipid mixtures. In
order to offer a more in-depth view on the interaction of G15
with different model membranes mimicking bacterial and tumor
cell membranes, the information gathered in the present study
will be coupled with the results provided by the on going
investigations on different granulysin peptides [1,12,13].Fig. 1. Amino acid sequence of the peptide dimer G15.2. Materials and methods
2.1. Materials
POPG, POPC, d31-POPC, and E. coli total lipid extract were purchased from
Avanti Polar Lipids (Alabaster, AL). Chloroform, cholesterol and methanol were
procured from Aldrich Chemical Inc. (Milwaukee, WI). Naphthalene was from
Fisher Scientific (Pittsburgh, PA). Buffers were prepared using water obtained
from NONApure A filtration system. All the chemicals were used without
further purification. The synthesis of the peptide G15 was published elsewhere
[1].
2.2. Outer membrane disruption assay
The outer membrane permeabilizing ability of the peptide was investigated
using the 1-anilinonaphthalene-8-sulfonic acid (ANS) uptake assay [14,15],
using E. coli strain BL21 (DE3). Bacterial cells from an overnight culture were
inoculated into LB medium. Cells from the mid-log phase were centrifuged and
washed with Tris-buffer (10 mM Tris, 150 mM NaCl, pH 7.4), and then
resuspended in Tris-buffer to an OD600 of 0.065. To a 3.0 mL of the cell
suspension in a cuvette, a stock solution of ANS was added to a final
concentration of 5.0 μM. The degree of membrane disruption as a function of
peptide concentration was observed by the increase in fluorescence intensity at
∼500 nm.
2.3. Solid-State NMR
Multilamellar vesicles (MLVs) (or unoriented bilayers) were prepared by
mixing the required amounts of lipid and peptide in 2:1 chloroform:methanol.
The solution was first dried under N2 gas and then under vacuum overnight to
completely remove any residual organic solvents. The mixture was resuspended
in 50 wt.% water by heating in a water bath at 45 °C. The samples were vortexed
for 3 min and freeze–thawed using liquid nitrogen several times to obtain a
uniform mixture of lipid and peptide. All MLV samples were stored at −20 °C
prior to use.
Mechanically aligned POPC/POPG (3:1) and E. coli total lipid bilayers were
prepared using the procedure described by Hallock et al. [16]. Briefly, 4 mg of
lipids and an appropriate amount of peptide were dissolved in CHCl3/CH3OH
(2:1) mixture. The sample was dried under a stream of nitrogen and re-dissolved
in CHCl3/CH3OH (2:1) mixture containing equimolar quantities of naphthalene.
An aliquot of the solution (∼300 μL) was spread on two thin glass plates
(11 mm×22 mm×50 μm, Paul Marienfeld GmbH and Co., Bad Mergentheim,
Germany). The samples were then air-dried and kept under vacuum at 35 °C for
at least 15 h to remove naphthalene and any residual organic solvents. After
drying, the samples were hydrated at 93% relative humidity using saturated
NH4H2PO4 solution [17] for 2–3 days at 37 °C, after which approximately 2 μL
of H2O was misted onto the surface of the lipid–peptide film. The glass plates
were stacked, wrapped with parafilm, sealed in plastic bags (Plastic Bagmart,
Marietta, GA), and then kept at 4 °C for 6–24 h.
All NMR spectra of were obtained from a Varian Infinity 400 MHz solid-
state NMR spectrometer operating at resonance frequencies of 400.138,
161.979, and 61.424 MHz for 1H, 31P, and 2H nuclei, respectively. A
Chemagnetics temperature controller was used to maintain the sample
temperature, and each sample was equilibrated at 30 °C for at least 30 min
before the experiment was started. A home-built double resonance probe, which
has a four-turn square-coil (12 mm×12 mm×4 mm) constructed using a 2-mm
wide flat-wire and a spacing of 1 mm between turns, was used for experiments
on aligned samples and a triple-resonance MAS probe was used for experiments
on MLVs. In the case of aligned samples, the lipid bilayers were positioned in
such a way that the bilayer normal was parallel to the external magnetic field of
the NMR spectrometer. A typical 31P 90°-pulse length of 3.1 μs was used. 31P
spectra were obtained using a spin-echo sequence (90°–τ–180° with τ=100 μs),
40 kHz rf field for time proportional phase modulation decoupling of protons
[18], 50 kHz spectral width, and a recycle delay of 3 s. A typical spectrum
required the co-addition of 500–800 transients for aligned samples and about
4000 transients for MLVs. The 31P chemical shift spectra are referenced relative
to 85% H3PO4 (0 ppm) [16]. A quadrupole echo pulse sequence (90°–τ–90°
Fig. 2. G15-induced ANS uptake into E. coli membranes. Fluorescence
spectrum of ANS equilibrated with E. coli cells (trace 1), and in the presence of
4.3 μM (trace 2), 8.6 μM (trace 3), 12.9 μM (trace 4) and 17.2 μM (trace 5) and
21.6 μM (trace 6) concentrations of G15. The E. coli cell density, as measured at
OD600, was 0.065.
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accomplished using the Spinsight software (Varian) on a Sun Sparc workstation.
2.4. Fluorescence spectroscopy
The steady state fluorescence emission spectra of peptide–vesicle mixtures
were measured on a FluoroMax2 spectrofluorimeter (Jobin Yvon-Spex
Instruments, S.A. Inc. Edison, NJ). To a 7.8-μM solution of G15 in Tris-buffer
(10 mM Tris, 100 mMNaCl, 2 mMEDTA, pH 7.4), increasing amounts of small
unilamellar vesicles (SUVs) made of E. coli total lipids, POPC/POPG (3:1) or
POPC/POPG/Chl (9:1:1) were added and the changes in the fluorescence of the
intrinsic tryptophan residue were recorded. Spectra were recorded 5 min after
each addition of lipids to allow equilibrium binding. The excitation wavelength
was set at 295 nm with a bandwidth of 5 nm. For the red edge excitation shift
measurements, the peptide was incubated with POPC/POPG (3:1) liposomes
(500 μM) for 60 min to achieve equilibrium binding.
2.5. Dye leakage assay
Carboxyfluorescein dye entrapped SUVs were prepared as described
elsewhere [15]. Briefly, Tris-buffer containing 50 mM dye was added to the
dry lipid film, vortexed and sonicated. The dye-containing vesicles were then
purified by gel filtration chromatography, using a Sephadex G-75 column. To
an aliquot of vesicle suspension (60 μM lipid) in Tris-buffer, serial
concentrations of peptides were added and the fluorescence emission intensity
at 520 nm was recorded as a function of time using the excitation wavelength
490 nm. The maximum leakage from each sample was determined by adding
1% triton X-100.
2.6. Circular dichroism
Small unilamellar vesicles were prepared by sonication. Different lipids in
appropriate proportions were dissolved in chloroform and the clear solution was
taken to dryness. Tris-buffer was added to dry lipid film and subjected to vortex
and sonication to obtain a clear dispersion of SUVs. CD spectra were recorded
(AVIV CDS Model 62DS spectropolarimeter, Lakewood, NJ) at 25 °C using
samples with a peptide/lipid ratio of about 1:50 in a quartz cuvette (path
length=0.1 cm) over the range from 200 to 250 nm. Minor contributions from
the buffer and SUVs were removed by subtracting the spectra of the
corresponding control sample without peptide. The resultant spectra were
normalized for path length and concentration.
3. Results
3.1. Disruption of E. coli membrane
A subset of granulysin peptides corresponding to helix2–
loop–helix3 region of granulysin, exhibit potent lytic
activities against microbes, red blood cells and human
tumor cells [1,5,12]. The peptide G15 shows antimicrobial
activity against the Gram-negative bacteria at micromolar
concentrations and is slightly less active than the parent
peptide granulysin [1]. Since granulysin increases membrane
permeability of E. coli [5], it is likely that G15 exerts its
activity by permeabilizing the bacterial membrane. There-
fore, G15-induced bacterial membrane disruption was
monitored using ANS uptake assay [14,15]. The ANS
(5 μM) equilibrated with E. coli cells (OD600=0.0605)
showed an emission maximum at ∼519 nm (Fig. 2, trace 1).
Successive addition of 8 μL (4.3 μM) aliquots of G15 to a
3 mL cell suspension resulted in an enhancement in the
fluorescence intensity of ANS and a shift in the emission
maximum. At 152 μg/mL peptide concentration, theobserved emission maximum was ∼510 nm. The blue
shift in the emission maximum and the enhancement in the
fluorescence intensity of ANS indicate that ANS relocates
into a relatively less polar environment, presumably, the
bacterial membrane as a consequence of outer membrane
disruption by G15. However, ANS showed a blue shifted
emission maximum at ∼497 nm when 27.7 μg/mL of G8,
the cell-lytic antimicrobial peptide derived from granulysin,
was used against E. coli pretreated with ANS dye (data not
given). These results suggest that G15 is a weaker
membrane-disrupting agent than the lytic peptide G8.
Since G15 exhibited a moderate disruption of E. coli outer
membrane, its ability to disrupt bacterial inner membrane was
assessed using model membranes and 31P NMR experiments.
Mechanically aligned bilayers formed of E. coli lipids gave a
broad signal in the range from 22 ppm to 30 ppm with the major
component centered at ∼25 ppm (Fig. 3). All spectra (with and
without the peptide) also show a broad low signal-to-noise ratio
signal from 22 ppm to −6 ppm, which could originate from the
unoriented part of the sample. On the other hand, E. coli lipid
bilayers incorporated with G15 show a peak at −10 ppm that
increases the intensity with the increase of the peptide
concentration from 1 to 5 mol%. Even though some of this
signal could be due to the unoriented part of the lipid sample on
glass plates, some of this could be due to the formation of a
lipid–peptide complex that disorders (either conformationally
and/or dynamically) the head group region of lipids. To confirm
this observation and interpretation, we repeated the experiments
two times on each sample and the spectra were reproducible. In
addition, three different samples were prepared for each P:L and
the experiments produced identical results for each P:L. Also,
from our experience, the aligned samples prepared using the
naphthalene procedure are well hydrated, quite stable and the
results have been reproducible [16,19–26]; such observations
were also reported from another independent study on an
antimicrobial peptide [27]. Experimental results on the
interaction of the peptide with anionic membrane are given
below (Figs. 7 and 8). Therefore, these results show the ability
of the peptide to moderately disrupt bacterial inner membrane,
Fig. 3. 31P chemical shift spectra of oriented E. coli lipid bilayers in the absence
and presence of G15 at 25 °C. The bilayer normal was parallel to the external
magnetic field of the spectrometer.
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on the ANS uptake assay.
The consequences of G15 binding to the SUVs formed of E.
coli lipids were also examined. The fluorescence property of the
two tryptophan-residues present in G15 was exploited to assess
the binding interactions. The fluorescence emission spectrum of
G15 (6.3 μM) dissolved in Tris buffer (pH 7.4) showed an
emission maximum at ∼354 nm. When aliquots from a 5-mM
stock suspension of E. coli lipid vesicles were added to the
peptide solution, the fluorescence intensity decreased signifi-
cantly, indicating a tight binding of G15 at the bilayer interface
[28]. The peptide-vesicle suspension turned slightly turbid
when higher amounts of vesicles were added, suggesting a
peptide-induced aggregation of vesicles. Fig. 4 shows theFig. 4. Stern–Volmer plot derived from the fluorescence quenching of G15 by
the addition of E. coli total lipid vesicles. Aliquots from a 5-mM stock
suspension of lipid vesicles were added to G15 (6.3 μM) in Tris buffer. The
intensity of fluorescence at the emission maximum 254 nm was measured after
excitation at 295 nm. The excitation and emission bandwidths were kept at 5 nm.
F0 and F are the fluorescence intensities in the absence and presence of lipid
vesicles, respectively. For each sample, a blank spectrum was recorded and
subtracted from the sample spectrum.Stern–Volmer plot of the quenching of G15 fluorescence by the
SUVs formed of E. coli lipids.
3.2. Interaction with negatively charged membranes
It has recently been shown that the lipid composition of a
model membrane modulates peptide activity [21–23,25].
Studies on granulysin protein proposed that the electrostatic
interaction between the anionic bacterial inner membrane and
the highly positive charged granulysin (there are 15 positively
charged residues) would be an important factor in its
antimicrobial activity [5]. Therefore, in this study, we
investigated the interaction of G15 with model membranes
with different compositions to understand the role of an anionic
lipid in the activity of G15 and the molecular basis for cell-
selective interactions. The trace 1 of Fig. 5 is the steady state
fluorescence emission spectrum of G15 (6.3 μM) in Tris buffer
(pH 7.4). Addition of aliquots of SUVs (100 μM) to the peptide
resulted in an enhancement in the fluorescence intensity and a
shift in the emission maximum of G15 (Fig. 5, traces 2–6). As
shown in Fig. 6 (trace A), there is a shift towards lower
wavelengths in the emission maximum of G15 upon binding to
POPC/POPG (3:1) vesicles. These data indicate that G15 binds
to negatively charged membranes and that the tryptophan
residue relocates into a relatively less polar environment [29].
A polar fluorophore, like tryptophan when present in a
viscous medium, exhibits excitation wavelength-dependent
fluorescence emission maximum. The difference in the
emission maximum after excitation at the red edge of the
absorption spectrum is called the red edge excitation shift
(REES), and is indicative of a restricted motion of the
tryptophan residue [30]. Fig. 6 (trace B) shows the excitation
wavelength-dependent shift in the fluorescence emission
maximum of tryptophan for G15 bound to POPC/POPG (3:1)
liposomes. As shown in Fig. 6, a REES value of 2 nm was
observed. The low REES value is in accordance with an
interfacial localization of tryptophan residue [31].
Since the G15 peptide is cationic (net charge is +3) and the
31P chemical shift of the lipid is highly sensitive to the charge
density on the bilayer surface, the binding of G15 to the bilayersFig. 5. Fluorescence emission spectra of G15 (6.3 μM) upon binding to (1) 0, (2)
100, (3) 200, (4) 300, (5) 400 and (6) 500 μM of POPC–POPG (3:1) lipid
vesicles.
Fig. 6. Blue shift in fluorescence emission maximum of G15 (▴; 6.3 μM) upon
binding to POPC–POPG (3:1) vesicles (100, 200, 300, 400 and 500 μM), and
REES in the fluorescence emission maximum of G15 (▵; 6.3 μM) bound to
500 μM lipid vesicles. The peptide was mixed with POPC–POPG (3:1) vesicles
(500 μM) and incubated for 1 h. The lipid/peptide molar ratio was ∼80:1. The
fluorescence emission spectra of G15 were recorded using various excitation
wavelengths ranging from 280 to 305 nm. A bandwidth of 5 nm was used for
both emission and excitation. For each sample, a blank spectrum was recorded
and subtracted from the sample spectrum.
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performed on well-aligned bilayers at 37 °C showed peptide-
induced changes in the 31P chemical shift. A single narrow line
at the higher frequency (or the parallel) edge of the powder
pattern was observed as reported in our earlier publications
(data not shown for pure POPC and pure POPG) [16,19–26].
The 31P chemical shift spectrum of oriented bilayers made of
POPC/POPG (3:1) lipids shows two peaks in the range from 25
to 29 ppm, originating from the phosphate groups of POPG and
POPC lipids, respectively (Fig. 7). When POPC/POPG (3:1)
bilayers are incorporated with 1–5 mol% G15, the two peaks
coalesce to give a symmetric peak centered at ∼27 ppm. TheseFig. 7. 31P chemical shift spectra of oriented POPC/POPG (3:1) lipid bilayers in
the absence and presence of G15 at 25 °C. The bilayer normal was parallel to the
magnetic field.data suggest that the peptide binding to lipid bilayers affects the
conformation of the lipid head group in both POPC and POPG
lipids [19–27]. To further confirm these results, 31P NMR
experiments were also carried out on static MLVs to measure
the peptide-induced changes in the chemical shift span and the
line shape. The 31P chemical shift spectra of pure POPC, 3:1
POPC:POPG and POPG MLVs at 37 °C showed typical
lamellar phase powder patterns with a chemical shift span of
46±1.5, 38±1.5 and 35±1.5 ppm, respectively. These chemical
shift anisotropy values are in good agreement with the reported
studies in the literature [32]. The inclusion of G15 peptide (up to
10 mol% peptide) did not show significant observable changes
(within experimental errors) in the spectral line shape of POPC
bilayers while observable increase in the CSA span was
observed in POPG containing bilayers. For example, the CSA
span values measured from POPC, 3:1 POPC:POPG and POPG
MLVs containing 5 mol% G15 at 37 °C were 47±1.5, 40±1.5
and 38±1.5 ppm, respectively. Sample spectra are shown for
3:1 POPC:POPG bilayers in Fig. 8 (A). On the other hand,
increase of peptide concentration to 10 mol% increased the
CSA span to 47±1.5 ppm in 3:1 POPC:POPG bilayers. This
peptide-induced increase in the CSA is in good agreement with
the previous studies on the effect of cations on lipid bilayers
[33]. Interestingly, the increase in observed CSA correlates with
the increase in the presence of an anionic lipid (that is POPG) in
the bilayer suggesting that the peptide G15 preferentially bindsFig. 8. (A) 31P chemical shift spectra of 3:1 POPC:POPG multilamellar
vesicles with different concentrations of G15 peptide (given in mol%). (B)
Variation of 31P isotropic chemical shift of 3:1 POPC:POPG multilamellar
vesicles under 3±0.005 kHz MAS as a function of the concentration of G15
peptide. The isotropic chemical shift value of POPG (open circles) was set to
0 ppm while that of POPC (filled triangles) was at −1.3 ppm in the absence of
the peptide. A 0.25-ppm experimental error in the chemical shift value was
measured from the full width at half maximum.
Fig. 9. Peptide induced dye leakage from POPC/POPG (3:1) vesicles. Lipid
concentration was 60 μM. The concentration of peptide G15 was 7.8 μM.
Arrows 1 and 2 indicate the time of addition of peptide and triton X-100,
respectively. Inset shows the blown up image of the initial leakage. The
concentration of peptide G8 was 5.5 μM. The hemolytic and antimicrobial
peptide G8 was used as a control.
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promotes the formation of non-lamellar phase structures such as
cubic and hexagonal phases nor fragments the MLVs to micelles
or SUVs.
In addition to the results obtained from oriented bilayers
(Figs. 3 and 7) and static MLVs, magic angle spinning (MAS)
31P NMR experiments were performed on MLVs at 37 °C.
Observed spectra contained a narrow line for pure POPC and
two narrow lines for 3:1 POPC:POPG separated by about
1.2 ppm (low field peak corresponds to POPG and the high field
peak corresponds to POPC) as shown in a recent study on
DMPC and DMPG bilayers [33]. The 31P isotropic chemical
shift frequency was measured from POPC and 3:1 POPC:POPG
bilayers in the presence and absence of G15. While the addition
of G15 to POPC bilayers did not alter the 31P peak position, an
upfield shift of both the 31P peaks corresponding to POPC and
POPG lipids in 3:1 POPC:POPG bilayers was observed. The
upfield shift in the isotropic 31P chemical shift value of the
POPG is greater than that of the POPC value as shown in Fig.
8B. These results demonstrate that the presence of an anionic
lipid (POPG) promotes the binding of the peptide G15 to
bilayers and confirm the peptide-induced head group confor-
mation change of POPG lipids. In addition, notable peptide-
induced changes were measured in the 31P spin-lattice
relaxation (T1) values of MLVs at 37 °C under MAS. The
addition of 5 mol% peptide slightly increased the T1 value from
775±10 to 785±10 ms in POPC bilayers (Table 1). On the other
hand, the addition of 5 mol% G15 increased the T1 values for
both POPC and POPG lipids in 3:1 POPC:POPG bilayers.
However, the increase in the T1 value of POPG (from 785±10
to 850±10 ms) is significantly larger than that of POPC lipid
(from 780±10 ms to 805±10 ms). The increase in T1 values in
the presence of G15 suggests that the lipid–peptide interaction
most likely reduces the axial rotational motion of the lipids,
which could make the T1 relaxation mechanism less efficient as
reported in a recent study [34]. These results further confirm the
preference of the peptide to bind with anionic lipids in the
bilayer.
A number of antimicrobial peptides that insert into
negatively charged vesicles have been reported to induce
leakage of vesicular contents [35]. Since G15 interacts with
POPC/POPG (3:1) vesicles and disorders the head group region
of lipids, its ability to induce dye leakage from lipid vesicles
was studied using fluorescence method. Carboxyfluoresceine
dye entrapped POPC/POPG (3:1) SUVs (60 μM) were
suspended in Tris buffer (pH 7.4) and aliquots of peptideTable 1
The 31P spin-lattice relaxation, T1, values measured from pure and G15-
containing multilamellar vesicles using magic angle spinning solid-state NMR
experiments at 37 °C
Sample Lipid T1 for
pure lipid
T1 for 5
mol% G15
POPC POPC 775±10 785±10
3:1 POPC:POPG POPC 785 850
3:1 POPC:POPG POPC 780 805
The experimental error was 10 ms.solutions were added. Fig. 9 shows the dye leakage profile upon
the addition of G15 (7.8 μM) and G8 (5.5 μM). As shown in
Fig. 9, the lytic peptide G8 induces significant dye leakage from
POPC/POPG (3:1) vesicles at a lipid to peptide ratio of 11:1,
while G15 fails to induce significant dye release even at a lipid
to peptide ratio of 8:1.
One important component present in mammalian cell
membranes is cholesterol (Chl), which is absent in bacterial
membranes [36,37]. We examined the equilibrium binding of
G15 to vesicles formed from a 9:1:1 mixture of POPC, POPG,
and Chl, which approximates the charge characteristics of
mammalian tumor cell membrane [38]. Fig. 10 shows the steady
state fluorescence spectra of G15 (7.8 μM) in Tris buffer (pH
7.4) and in the presence of 150 μM POPC/POPG/Chl (9:1:1)
lipid vesicles; data obtained for 25, 50, 75, 100, and 125 μM
POPC/POPG/Chl (9:1:1) lipid vesicles were similar to 150 μMFig. 10. Fluorescence emission spectra of G15 (7.8 μM) in the absence (solid
line) and presence (dashed line) of POPC/POPG/Chl (9:1:1) lipid vesicles
(150 μM). The excitation wavelength was 295 nm. Spectra were normalized
after subtracting the contributions from buffer and lipid vesicles.
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residue is slightly quenched by the addition of POPC/POPG/
Chl (9:1:1) vesicles. Considering the experimental error in these
measurements, the observed quenching might indicate a very
weak interaction between G15 and POPC/POPG/Chl (9:1:1)
vesicles or no interaction at all. To confirm whether the weak
interaction leads to leakage of vesicular contents, aliquots of
G15 (up to 7.8 μM) were added to SUVs (60 μM) formed of
POPC/POPG/Chl (9:1:1) mixture. Peptide G8 was used as a
control. While G8 induced ∼4% leakage at a concentration of
5.5 μM, G15 failed to cause any significant leakage from
POPC/POPG/Chl (9:1:1) vesicles even at concentration of
7.8 μM (data not shown).
3.3. Circular dichroism
Since the interactions of G15 with different types of model
membranes were distinct, we studied the secondary structure of
the peptide in the presence of different model membranes. The
CD spectrum of G15 in aqueous buffer (pH 7.4) exhibited a
negative minimum at ∼204 nm, suggesting a random coil
conformation (Fig. 11). When SUVs made of E. coli lipids were
added, the suspension turned turbid and hampered CD
measurements. These observations appeared as a sign of
peptide-induced aggregation of E. coli lipid vesicles. However,
in the presence of SUVs formed of POPC/POPG (3:1) lipid
mixture, the peptide showed a negative minimum at ∼206 nm
and another shallow negative minimum at ∼220 nm, indicating
a relatively less ordered conformation, possibly consisting
nascent helical turns upon inserting into membrane bilayers.
Interestingly, addition of POPC/POPG/Chl (9:1:1) liposomes to
the G15 solution did not induce any transitions in the
conformation of the peptide. The CD profiles of G15 in buffer
and in the presence of POPC/POPG/Chl (9:1:1) vesicles were
comparable and omitted for clarity. These observations suggest
that the peptide exerts minimal or no perturbations in
cholesterol containing lipid vesicles.Fig. 11. Circular dichroism spectra of G15 (31.6 μM) in Tris buffer (10 mM Tris,
150 mM NaCl, 2 mM EDTA, pH 7.4), (open diamonds) and POPC/POPG (3:1)
lipid vesicles (filled diamonds). Lipid–peptide molar ratio was ∼50:1. Spectra
were normalized after subtracting the contributions from buffer and lipid
vesicles.4. Discussion
Several antimicrobial peptides bind preferentially to anionic
lipids that may form the basis for microbial specificity since
bacterial lipid membranes have a net positive charge because of
the presence of acidic phospholipids. The significance of
specific peptide–lipid interactions has been studied to elucidate
the mechanism of antimicrobial action [39]. The mechanisms of
cytotoxicity of several antimicrobial peptides have been
attributed to their ability to permeabilize the plasma membrane
[40]. The differences in the degree of toxicity exerted by these
peptides are likely to be associated with the differences in the
composition of membranes. Granulysin, and short peptides
derived from it, disrupt synthetic liposomes and exhibit activity
against bacteria and human Jurkat cells [1,5]. It has been
proposed that the mechanism of lysis of bacteria and tumor cells
by ganulysin peptides are different [1]. Unlike other granulysin
peptides that are also active against tumor cells, G15 does not
show any activity against human Jurkat cells [1]. The interesting
observation in this study is that the mode of interaction of G15
with different types of model membranes is distinct and differs
substantially from each other.
Non-hemolytic cationic peptides have been shown to exhibit
potent antimicrobial activity, which could be explained by their
potential binding to the negatively charged surface of bacteria
[15,39]. In agreement with this assumption, G15 binds to and
disrupts E. coli outer membrane (Fig. 2) in a concentration
dependent manner. However, G15-induced membrane disrup-
tion is only marginal when compared with the disruption caused
by G8, a cell lytic peptide derived from granulysin. Thus, G15
appears to be a weak membrane-disrupting agent, which is in
agreement with its high MIC value against Gram-negative
bacteria [1]. Previous research has shown that short antimicro-
bial peptides that are unable to disrupt bacterial outer membrane
destroy the membrane barrier function without pore formation
[41,42]. The ability of G15 to induce disorders in bilayers made
of E. coli total lipids (Fig. 3) suggests a direct interaction of the
peptide with bacterial membranes. However, the addition of E.
coli total lipid vesicles to the peptide solution was accompanied
by a reduction in the fluorescence intensity with no blue shift of
λmax. This suggests a tight binding of the peptide to the lipid
bilayers, a limited insertion of the peptide into the hydrophobic
core of the membrane and a possible interaction of tryptophan
residues with the phosphate head groups [29].
E. coli lipid mixture contains PE, PG and cardiolipin, out of
which PE and cardiolipin have a tendency to form hexagonal
phases upon interaction with polycations [20,23,43–45]. These
interactions may have a role in the formation of nonbilayer
structures such as cubic, hexagonal or micelles. However, the
31P NMR data shown in Figs. 3, 7 and 8A did not show peaks
corresponding to non-lamellar phase formation in bilayers and
therefore it is unlikely that the G15 peptide functions via non-
lamellar phase formation. Thus, neither a ‘toroidal’ nor a ‘barrel
stave’mechanism would explain the membrane activity of G15.
Given the structure of G15 bound to liposomes, and in aqueous
buffer (Fig. 11), a ‘carpet’ mechanism leading to the formation
of local defects in the membrane is a possibility [46].
161A. Ramamoorthy et al. / Biochimica et Biophysica Acta 1758 (2006) 154–163For short antimicrobial peptides such as G15, it would be
intriguing to investigate whether they act by different
mechanisms. Our studies indicate that the peptide G15
interacts strongly with POPC/POPG (3:1) and E. coli total
lipid membranes. However, the mode of interaction with
different model membranes is distinct; this is in agreement
with the increase in the isotropic chemical shift values (shown
in Fig. 8) and the increase in the T1 values, which suggested
that the peptide prefers to bind with anionic lipid bilayers
containing POPG as opposed to a neutral bilayers containing a
zwitterionic lipid POPC. These results also suggest that the
cationic peptide binding alters the conformation of the lipid
head group as reported in the literature [32,33]. While the
binding of G15 to E. coli lipid vesicles results in the
quenching of fluorescence from the intrinsic tryptophan
residue, binding to POPC/POPG (3:1) liposomes is followed
by an increase in the quantum yield of tryptophan. A shift in
the emission maximum from 354 nm to 348 nm was also
observed, and is in agreement with the insertion of tryptophan
residue and possibly the hydrophobic side chains into POPC/
POPG (3:1) bilayers. A blue shift of 6 nm and a REES value
of 2 nm in the λmax of tryptophan (Fig. 6) suggest that the
tryptophan residue is located at the bilayer interface and not
deep inside the hydrophobic region of the membrane
[29,47,48]. This assumption is supported by the peptide's
inability to induce significant dye-leakage from vesicles
formed of POPC/POPG (3:1) mixture (Fig. 9). Inhibition of
leakage from anionic liposomes has been previously reported
for cationic peptides melittin, nisin, and mastoparan and for
the synthetic peptide KLAL [47–50]. Moreover, incorporation
of G15 into POPC/POPG (3:1) bilayers does not result in
substantial disintegration or micellization of the membrane
(both unoriented MLVs and oriented bilayers) (Figs. 3 and 7).
Thus, solubilization of membrane bilayers through a deter-
gent-like mechanism is ruled out due to the absence of any
isotropic signal in the 31P NMR spectra of the peptide
incorporated bilayers formed of POPC/POPG (3:1) mixture as
well as E. coli total lipids (Figs. 3 and 7). These results are in
agreement with recent NMR studies on the interaction of
antimicrobial peptides with lipid bilayers [19–27,51–58].
Whereas the fluorescence properties of the intrinsic trypto-
phan residue are affected by the presence of vesicles formed of
E. coli lipids and POPC/POPG (3:1) mixture, relatively
insignificant changes are observed when vesicles made of
POPC/POPG/Chl (9:1:1) mixture are added to the peptide
solution (Fig. 11). This clearly suggests that G15 does not insert
into POPC/POPG/Chl (9:1:1) membrane. Presence of 3–9%
phosphatidylserine makes cancer cell membranes negatively
charged [36]. We evaluated the effect of G15 on liposomes
formed of POPC/POPG/Chl (9:1:1) mixture, which approx-
imates the charge characteristics of cancer cell membrane.
Previous studies have demonstrated that incorporation of
cholesterol imparts rigidity to the membrane and weakens the
interaction between the peptides and membrane [19,20,59–61].
In our experiments, the reduction in negative charge (low POPG
content) and an increase in membrane rigidity (incorporation of
cholesterol) may have limited the binding of G15 to liposomesmade of POPC/POPG/Chl (9:1:1) mixture. Accordingly, the
peptide does not induce any dye leakage from liposomes made
of POPC/POPG/Chl (9:1:1) (data not shown). Thus, the
inability of the peptide to bind and perturb POPC/POPG/Chl
(9:1:1) membrane could account for the peptide's inability to
lyse human Jurkat cells.
Several strategies have been used to improve antimicrobial
activity and cell selectivity of synthetic peptides. They include:
fatty acylation of synthetic peptides, cyclization of linear
peptides, substitution of unusual amino acids, and total or
partial replacement by D-amino acids. Dimerization of magainin
2 has been shown to exhibit improved activity against various
microorganisms and synthetic liposomes [62]. Our study also
shows that dimerization through disulfide bond formation could
possibly be used as a strategy to impart antimicrobial activity
and cell selectivity.
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